Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2013 1
2014 1
2017 1
2018 2
2020 1
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
CD8+ T Cell Exhaustion in Cancer.
Dolina JS, Van Braeckel-Budimir N, Thomas GD, Salek-Ardakani S. Dolina JS, et al. Front Immunol. 2021 Jul 20;12:715234. doi: 10.3389/fimmu.2021.715234. eCollection 2021. Front Immunol. 2021. PMID: 34354714 Free PMC article. Review.
Combinatorial immunotherapy induces tumor-infiltrating CD8+ T cells with distinct functional, migratory, and stem-like properties.
Van Braeckel-Budimir N, Dolina JS, Wei J, Wang X, Chen SH, Santiago P, Tu G, Micci L, Al-Khami AA, Pfister S, Ram S, Sundar P, Thomas G, Long H, Yang W, Potluri S, Salek-Ardakani S. Van Braeckel-Budimir N, et al. Among authors: dolina js. J Immunother Cancer. 2021 Dec;9(12):e003614. doi: 10.1136/jitc-2021-003614. J Immunother Cancer. 2021. PMID: 34903555 Free PMC article.
Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4+ T Cell-Independent CD8+ T-Cell Response Against Unconjugated Protein Antigen.
Chiodetti AL, Sánchez Vallecillo MF, Dolina JS, Crespo MI, Marin C, Schoenberger SP, Allemandi DA, Palma SD, Pistoresi-Palencia MC, Morón G, Maletto BA. Chiodetti AL, et al. Among authors: dolina js. Front Immunol. 2018 Oct 10;9:2319. doi: 10.3389/fimmu.2018.02319. eCollection 2018. Front Immunol. 2018. PMID: 30364187 Free PMC article.
12 results